Published in Antimicrob Agents Chemother on June 01, 2002
Peptide antimicrobial agents. Clin Microbiol Rev (2006) 6.04
Interactions of histatin 5 and histatin 5-derived peptides with liposome membranes: surface effects, translocation and permeabilization. Biochem J (2004) 1.14
One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis. Infect Immun (2003) 1.04
Reactive oxygen species play no role in the candidacidal activity of the salivary antimicrobial peptide histatin 5. Biochem J (2004) 0.93
Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species. Antimicrob Agents Chemother (2003) 0.93
N-acetylcysteine amide decreases oxidative stress but not cell death induced by doxorubicin in H9c2 cardiomyocytes. BMC Pharmacol (2009) 0.92
The role of released ATP in killing Candida albicans and other extracellular microbial pathogens by cationic peptides. Purinergic Signal (2007) 0.90
Pro-oxidant and antioxidant effects of N-acetylcysteine regulate doxorubicin-induced NF-kappa B activity in leukemic cells. Mol Biosyst (2011) 0.89
MNN5 encodes an iron-regulated alpha-1,2-mannosyltransferase important for protein glycosylation, cell wall integrity, morphogenesis, and virulence in Candida albicans. Eukaryot Cell (2006) 0.88
Involvement of the mitogen activated protein kinase Hog1p in the response of Candida albicans to iron availability. BMC Microbiol (2013) 0.81
Synthesis of a New Peptide-Coumarin Conjugate: A Potential Agent against Cryptococcosis. ACS Med Chem Lett (2015) 0.76
Antifungal Activity and Action Mechanism of Histatin 5-Halocidin Hybrid Peptides against Candida ssp. PLoS One (2016) 0.76
Evaluation of Oxidative DNA Damage Using an Alkaline Single Cell Gel Electrophoresis (SCGE) Comet Assay, and the Protective Effects of N-Acetylcysteine Amide on Zearalenone-induced Cytotoxicity in Chang Liver Cells. Toxicol Res (2013) 0.76
Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11. PLoS One (2016) 0.75
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro. PLoS One (2017) 0.75
Resistance of Candida species to fluconazole. Antimicrob Agents Chemother (1995) 9.04
Localization of mitochondria in living cells with rhodamine 123. Proc Natl Acad Sci U S A (1980) 7.31
Redox regulation of fos and jun DNA-binding activity in vitro. Science (1990) 7.09
The significance of iron in infection. Rev Infect Dis (1982) 6.66
Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med (2000) 5.90
Mitochondrial control of nuclear apoptosis. J Exp Med (1996) 5.01
Oxygen stress: a regulator of apoptosis in yeast. J Cell Biol (1999) 4.76
Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A (1990) 4.61
Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother (1996) 4.24
Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci U S A (1991) 3.07
Antifungal agents: chemotherapeutic targets and immunologic strategies. Antimicrob Agents Chemother (1996) 3.03
Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J Antimicrob Chemother (1995) 2.83
Oxidative stress and apoptosis. Pathophysiology (2000) 2.58
Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J (1994) 2.43
ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity (1997) 2.39
Contribution of the mitochondrial permeability transition to lethal injury after exposure of hepatocytes to t-butylhydroperoxide. Biochem J (1995) 1.98
Lest I forget thee, glutathione. Nature (1969) 1.95
The cellular target of histatin 5 on Candida albicans is the energized mitochondrion. J Biol Chem (1999) 1.87
Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients. Lancet (1996) 1.85
Amphotericins A and B, antifungal antibiotics produced by a streptomycete. I. In vitro studies. Antibiot Annu (1957) 1.77
Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans. J Biol Chem (1998) 1.69
Cellular thiols and reactive oxygen species in drug-induced apoptosis. J Pharmacol Exp Ther (2001) 1.60
Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients. AIDS (1994) 1.55
Quantitative analysis of cellular glutathione by flow cytometry utilizing monochlorobimane: some applications to radiation and drug resistance in vitro and in vivo. Cancer Res (1986) 1.54
DNA and redox state induced conformational changes in the DNA-binding domain of the Myb oncoprotein. EMBO J (1993) 1.44
Molecular mechanisms of yeast aging. Trends Biochem Sci (1998) 1.42
Resistant candidiasis. AIDS Res Hum Retroviruses (1994) 1.35
Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5. Antimicrob Agents Chemother (2000) 1.32
Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper. Mol Cell Biol (1997) 1.19
Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Biol Chem (1997) 1.17
Candidacidal activities of human lactoferrin peptides derived from the N terminus. Antimicrob Agents Chemother (2000) 1.16
Released ATP is an extracellular cytotoxic mediator in salivary histatin 5-induced killing of Candida albicans. Infect Immun (2000) 1.16
Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. Antimicrob Agents Chemother (2000) 1.16
Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infect Immun (2001) 1.13
Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Med Microbiol Immunol (1993) 1.12
Antibacterial activity in bovine lactoferrin-derived peptides. Antimicrob Agents Chemother (1997) 0.96
Thioredoxin redox control of cell growth and death and the effects of inhibitors. Chem Biol Interact (1998) 0.95
Glutathione and drug resistance. Cancer Invest (1996) 0.95
Apoptosis in human leukemic cells induced by lactoferricin, a bovine milk protein-derived peptide: involvement of reactive oxygen species. Biochem Biophys Res Commun (1997) 0.92
The use of dedicated peptide libraries permits the discovery of high affinity binding peptides. J Immunol Methods (1995) 0.90
Redox regulation of AMP synthesis in yeast: a role of the Bas1p and Bas2p transcription factors. Mol Microbiol (2000) 0.83
Glutathione oxidation and mitochondrial depolarization as mechanisms of nordihydroguaiaretic acid-induced apoptosis in lipoxygenase-deficient FL5.12 cells. Toxicol Sci (2000) 0.81
Role of mitochondrial membrane permeability transition in p-hydroxybenzoate ester-induced cytotoxicity in rat hepatocytes. Biochem Pharmacol (1999) 0.81
Generation of free radicals during the death of Saccharomyces cerevisiae caused by lipid hydroperoxide. Biosci Biotechnol Biochem (1999) 0.77
Molecular basis of resistance to azole antifungals. Trends Mol Med (2002) 2.48
Optimization and validation of multilocus sequence typing for Candida albicans. J Clin Microbiol (2003) 2.18
Large scale production of recombinant human lactoferrin in the milk of transgenic cows. Nat Biotechnol (2002) 1.92
Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unit. J Clin Microbiol (2002) 1.49
Requirement of flhA for swarming differentiation, flagellin export, and secretion of virulence-associated proteins in Bacillus thuringiensis. J Bacteriol (2002) 1.45
Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology (2002) 1.41
The success of acinetobacter species; genetic, metabolic and virulence attributes. PLoS One (2012) 1.39
Disruption of the ESX-5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation. Mol Microbiol (2012) 1.39
Genotyping of Candida orthopsilosis clinical isolates by amplification fragment length polymorphism reveals genetic diversity among independent isolates and strain maintenance within patients. J Clin Microbiol (2007) 1.32
Swarming differentiation and swimming motility in Bacillus subtilis are controlled by swrA, a newly identified dicistronic operon. J Bacteriol (2005) 1.23
Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria. Infect Immun (2008) 1.23
Rhinovirus increases human beta-defensin-2 and -3 mRNA expression in cultured bronchial epithelial cells. FEMS Immunol Med Microbiol (2003) 1.22
LL-37 directs macrophage differentiation toward macrophages with a proinflammatory signature. J Immunol (2010) 1.20
Comparison of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis adhesive properties and pathogenicity. Int J Med Microbiol (2013) 1.20
Maggot excretions/secretions inhibit multiple neutrophil pro-inflammatory responses. Microbes Infect (2007) 1.19
Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3. Peptides (2007) 1.16
Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1 lymphocyte responses. Eur J Immunol (2004) 1.14
Radiolabelled antimicrobial peptides for infection detection. Lancet Infect Dis (2003) 1.11
Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guérin. Immunology (2004) 1.11
In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains. Antimicrob Agents Chemother (2006) 1.07
Activity of human beta-defensin 3 alone or combined with other antimicrobial agents against oral bacteria. Antimicrob Agents Chemother (2003) 1.06
Use of antimicrobial peptides against microbial biofilms: advantages and limits. Curr Med Chem (2011) 1.06
Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother (2007) 1.04
Sustained response to interferon-ribavirin combination therapy predicted by a model of hepatitis C virus dynamics using both HCV RNA and alanine aminotransferase. Antivir Ther (2003) 1.03
Differences in Acinetobacter baumannii strains and host innate immune response determine morbidity and mortality in experimental pneumonia. PLoS One (2012) 1.03
Pharmacokinetics of oral fumarates in healthy subjects. Br J Clin Pharmacol (2004) 1.00
Antimicrobial peptides: therapeutic potential for the treatment of Candida infections. Expert Opin Investig Drugs (2002) 0.99
Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg. J Antimicrob Chemother (2003) 0.98
The synthetic N-terminal peptide of human lactoferrin, hLF(1-11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2004) 0.97
Identification and characterization of toxigenic Bacillus cereus isolates responsible for two food-poisoning outbreaks. FEMS Microbiol Lett (2002) 0.96
Role of swarming migration in the pathogenesis of bacillus endophthalmitis. Invest Ophthalmol Vis Sci (2006) 0.95
Differential requirement of the transcription factor Mcm1 for activation of the Candida albicans multidrug efflux pump MDR1 by its regulators Mrr1 and Cap1. Antimicrob Agents Chemother (2011) 0.94
Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections. Eur J Nucl Med Mol Imaging (2002) 0.94
High genetic polymorphism among Giardia duodenalis isolates from Sahrawi children. Trans R Soc Trop Med Hyg (2009) 0.94
Maggot secretions skew monocyte-macrophage differentiation away from a pro-inflammatory to a pro-angiogenic type. PLoS One (2009) 0.94
Comparative transcriptomic and phenotypic analysis of the responses of Bacillus cereus to various disinfectant treatments. Appl Environ Microbiol (2010) 0.93
Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species. Antimicrob Agents Chemother (2003) 0.93
Global gene expression profile for swarming Bacillus cereus bacteria. Appl Environ Microbiol (2011) 0.92
99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J Nucl Med (2004) 0.92
Swarming behavior of and hemolysin BL secretion by Bacillus cereus. Appl Environ Microbiol (2007) 0.92
Genotypic and phenotypic properties of Candida parapsilosis sensu strictu strains isolated from different geographic regions and body sites. BMC Microbiol (2010) 0.92
Analysis of cerebrospinal fluid inflammatory mediators in chronic complex regional pain syndrome related dystonia. Clin J Pain (2008) 0.91
FlhF, a signal recognition particle-like GTPase, is involved in the regulation of flagellar arrangement, motility behaviour and protein secretion in Bacillus cereus. Microbiology (2007) 0.91
Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infection. J Infect Dis (2007) 0.91
DNA microarray based on arrayed-primer extension technique for identification of pathogenic fungi responsible for invasive and superficial mycoses. J Clin Microbiol (2007) 0.91
AFLP genotyping of Candida metapsilosis clinical isolates: evidence for recombination. Fungal Genet Biol (2009) 0.91
Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes. J Clin Microbiol (2004) 0.90
Multiple actions of Lucilia sericata larvae in hard-to-heal wounds: larval secretions contain molecules that accelerate wound healing, reduce chronic inflammation and inhibit bacterial infection. Bioessays (2013) 0.89
Gingipains produced by Porphyromonas gingivalis ATCC49417 degrade human-β-defensin 3 and affect peptide's antibacterial activity in vitro. Peptides (2011) 0.89
Psoriasis is not associated with IL-12p70/IL-12p40 production and IL12B promoter polymorphism. J Invest Dermatol (2004) 0.89
In vitro pharmacokinetics of anti-psoriatic fumaric acid esters. BMC Pharmacol (2004) 0.88
Cryo-electron tomography analysis of membrane vesicles from Acinetobacter baumannii ATCC19606 T. Res Microbiol (2013) 0.88
Two patients with complete defects in interferon gamma receptor-dependent signaling. J Clin Immunol (2007) 0.88
Bacillus thuringiensis pulmonary infection: critical role for bacterial membrane-damaging toxins and host neutrophils. Microbes Infect (2007) 0.88
Susceptibility of Streptococcus mutans and Actinobacillus actinomycetemcomitans to bactericidal activity of human beta-defensin 3 in biological fluids. Antimicrob Agents Chemother (2005) 0.87
Fungicidal activity of the human peptide hepcidin 20 alone or in combination with other antifungals against Candida glabrata isolates. Peptides (2011) 0.86
Antimicrobial activity of human hepcidin 20 and 25 against clinically relevant bacterial strains: effect of copper and acidic pH. Peptides (2010) 0.86
Radiotracers for fungal infection imaging. Med Mycol (2010) 0.86
Comparative analysis of the bactericidal activities of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains. Antimicrob Agents Chemother (2007) 0.86
Radiochemical and biological characteristics of 99mTc-UBI 29-41 for imaging of bacterial infections. Nucl Med Biol (2002) 0.86
Contribution of surfactin and SwrA to flagellin expression, swimming, and surface motility in Bacillus subtilis. Appl Environ Microbiol (2012) 0.86
Inflammatory and antimicrobial responses to methicillin-resistant Staphylococcus aureus in an in vitro wound infection model. PLoS One (2013) 0.86
pH-dependent disruption of Escherichia coli ATCC 25922 and model membranes by the human antimicrobial peptides hepcidin 20 and 25. FEBS J (2013) 0.85
Three-dimensional human skin equivalent as a tool to study Acinetobacter baumannii colonization. Antimicrob Agents Chemother (2012) 0.85
Complement activation and inhibition in wound healing. Clin Dev Immunol (2012) 0.85
In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis. J Antimicrob Chemother (2012) 0.84
The ESX-5 associated eccB-EccC locus is essential for Mycobacterium tuberculosis viability. PLoS One (2012) 0.84
Candida albicans isolates with different genomic backgrounds display a differential response to macrophage infection. Microbes Infect (2006) 0.83
Antimicrobial peptide hLF1-11 directs granulocyte-macrophage colony-stimulating factor-driven monocyte differentiation toward macrophages with enhanced recognition and clearance of pathogens. Antimicrob Agents Chemother (2009) 0.83
Combinations of maggot excretions/secretions and antibiotics are effective against Staphylococcus aureus biofilms and the bacteria derived therefrom. J Antimicrob Chemother (2010) 0.83
A composite fibrin-based scaffold for controlled delivery of bioactive pro-angiogenetic growth factors. J Control Release (2009) 0.83
Identification and typing of the Candida parapsilosis complex: MALDI-TOF MS vs. AFLP. Med Mycol (2014) 0.82
Influence of culture medium on the resistance and response of Mycobacterium bovis BCG to reactive nitrogen intermediates. Microbes Infect (2005) 0.81
The antimicrobial peptide hLF1-11 drives monocyte-dendritic cell differentiation toward dendritic cells that promote antifungal responses and enhance Th17 polarization. J Innate Immun (2012) 0.81
A mucoadhesive polymer extracted from tamarind seed improves the intraocular penetration and efficacy of rufloxacin in topical treatment of experimental bacterial keratitis. Antimicrob Agents Chemother (2004) 0.81
New rapid methods cannot replace the current method to diagnose bloodstream infections. J Med Microbiol (2014) 0.81
The human lactoferrin-derived peptide hLF1-11 exerts immunomodulatory effects by specific inhibition of myeloperoxidase activity. J Immunol (2012) 0.81
Radiopharmaceuticals: new antimicrobial agents. Trends Biotechnol (2003) 0.80
Gather ye buds: fungus formation of the bladder after complicated cesarean section. Am J Obstet Gynecol (2008) 0.80
Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients. Antimicrob Agents Chemother (2002) 0.79
Bacillus thuringiensis membrane-damaging toxins acting on mammalian cells. FEMS Microbiol Lett (2014) 0.79
Phagocytosis, germination and killing of Bacillus subtilis spores presenting heterologous antigens in human macrophages. Microbiology (2009) 0.79
An adamantyl amino acid containing gramicidin S analogue with broad spectrum antibacterial activity and reduced hemolytic activity. Chemistry (2010) 0.79